Financials

News Ideas Discussions Technicals Forecast Seasonals

ESLA fundamentals

Overview Statements Statistics Dividends Earnings Revenue

The current financial position of Estrella Immunopharma, Inc.

Total assets of ESLA for Q3 25 is 2.44 M USD, 22.18% less than the previous Q2 25. And total liabilities increased by 42.65% in Q3 25 to 4.28 M USD.

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Q2 '25

Q3 '25

Total assets

Total liabilities

Income statement Balance sheet Cash flow

Currency: USD

Q1 '21

Q2 '21

Q3 '21

Q4 '21

Q1 '22

Q2 '22

Q3 '22

Q4 '22

Q1 '23

Q2 '23

Q1 '24

Q2 '24

Q3 '24

Q4 '24

Q1 '25

Q2 '25

Q3 '25

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—

—